S Rijal
Overview
Explore the profile of S Rijal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rijal S, Nahas Y, Prokhorenko S, Bellaiche L
Phys Rev Lett
. 2024 Sep;
133(9):096801.
PMID: 39270196
Vortex crystals are commonly observed in ultrathin ferroelectrics. However, a clear physical picture of origin of this topological state is currently lacking. Here, we show that vortex crystallization in ultrathin...
2.
Migliori G, Bhatia V, DAmbrosio L, Raviglione M, Rijal S
IJTLD Open
. 2024 Jun;
1(1):7-10.
PMID: 38919415
No abstract available.
3.
Shaw C, Imamura H, Downing T, Blackburn G, Westrop G, Cotton J, et al.
Antimicrob Agents Chemother
. 2019 Oct;
64(1).
PMID: 31658971
Understanding the mechanism(s) underpinning drug resistance could lead to novel treatments to reverse the increased tolerance of a pathogen. In this study, paromomycin (PMM) resistance (PMM) was induced in three...
4.
Teh T, Nguyen N, Moujalled D, Segal D, Pomilio G, Rijal S, et al.
Leukemia
. 2017 Jul;
32(2):303-312.
PMID: 28751770
Targeted therapies are frequently combined with standard cytotoxic drugs to enhance clinical response. Targeting the B-cell lymphoma 2 (BCL-2) family of proteins is an attractive option to combat chemoresistance in...
5.
Ionita G, Malviya A, Rajbhandari R, Schluter W, Sharma G, Kakchapati S, et al.
Int J Infect Dis
. 2017 May;
60:64-69.
PMID: 28483724
Objectives: To assess the prevalence of human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) co-infections among people living with HIV (PLHIV) in Nepal. Methods: A...
6.
Chaudhary R, Banskota B, Rijal S, Banskota A
JNMA J Nepal Med Assoc
. 2016 Aug;
53(199):198-201.
PMID: 27549506
Synovial chondromatosis is not so rare intra-articular condition secondary to synovial metaplasia, that affects the knee joint. Extra-articular synovial chondromatosis however is an extremely rare condition that usually involves the...
7.
Banskota B, Shrestha S, Chaudhary R, Rajbhandari T, Rijal S, Shrestha B, et al.
J Nepal Health Res Counc
. 2016 Jul;
14(32):51-7.
PMID: 27426712
Background: The anecdotal burden of morbidity secondary to motorbike accidents is thought to enormous by personnel involved in trauma care. The objective of the present study is to ascertain patterns...
8.
Shaw C, Lonchamp J, Downing T, Imamura H, Freeman T, Cotton J, et al.
Mol Microbiol
. 2015 Dec;
99(6):1134-48.
PMID: 26713880
In this study, we followed the genomic, lipidomic and metabolomic changes associated with the selection of miltefosine (MIL) resistance in two clinically derived Leishmania donovani strains with different inherent resistance...
9.
Hendrickx S, Eberhardt E, Mondelaers A, Rijal S, Bhattarai N, Dujardin J, et al.
J Antimicrob Chemother
. 2015 Aug;
70(11):3023-6.
PMID: 26253089
Objectives: Widespread antimony resistance in the Indian subcontinent has enforced a therapy shift in visceral leishmaniasis treatment primarily towards miltefosine and secondarily also towards paromomycin. In vitro selection of miltefosine...
10.
Hendrickx S, Boulet G, Mondelaers A, Dujardin J, Rijal S, Lachaud L, et al.
Parasitol Res
. 2014 Mar;
113(5):1875-81.
PMID: 24615359
Although widespread resistance of Leishmania donovani and L. infantum against miltefosine (MIL) and paromomycin (PMM) has not yet been demonstrated, both run the risk of resistance selection. Unraveling the dynamics...